Covid-19 vaccines for international donation

Ended Definitive Contract Awarded Last action

Contract number
W58P0521C0002
Awardee
Awarding agency
Obligated
$4,150,835,100

Award facts

Opportunity
  • W58P0521R0005 Solicitation number
Contract value 61% obligated
  • $4,150,835,100.00 Current, with exercised options
  • $6,859,517,906.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Bureau for Global Health Washington Office, US Agency for International Development
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
New York, NY 10017, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00029 · Coronavirus disease 2019 (COVID-19) global vaccine mission -$19,467,694
Other Administrative Action P00030 · To administratively closeout this award. $0
Other Administrative Action P00028 $0
Funding Only Action P00027 · Coronavirus disease 2019 (COVID-19) global vaccine mission $400,000
Other Administrative Action P00026 · Covid-19 vaccine -$9,364,401
Other Administrative Action P00024 · Coronavirus disease 2019 (COVID-19) global vaccine mission $0
Other Administrative Action P00022 · Administrative modification - coronavirus disease 2019 (covid- 19) global vaccine mission $0
Other Administrative Action P00025 · Covid-19 vaccine $0
Other Administrative Action P00023 · Coronavirus disease 2019 (COVID-19) global vaccine mission $19,267,194
Other Administrative Action P00021 $0
Supplemental Agreement for work within scope P00020 $0
Supplemental Agreement for work within scope P00019 · Covid-19 vaccine $0
Supplemental Agreement for work within scope P00018 · Covid-19 action the purpose of this modification is to DEO-obligate funds, which will be returned to US aid, so that they may fund their contract. In… -$40,000,001
Other Administrative Action P00017 · Covid-19 action update exhibit a $0
Supplemental Agreement for work within scope P00016 · Covid-19 vaccine $0
Supplemental Agreement for work within scope P00015 · The purpose of modification P00015 is to incorporate new option clins for covid vaccine and diluent, as well as amend the statement of work (SOW). $0
Other Administrative Action P00013 · Covid-19 vaccine: administrative modification to revise exhibit a for monthly deliveries/allocations IAW terms of the contract $0
Supplemental Agreement for work within scope P00014 · The purpose of modification P00014 is to "right size" the contract by reducing vaccine doses and diluent, as well as DE-obligate the corresponding funding in… -$2,747,500,001
Other Administrative Action P00012 · Update exhibit a: international delivery orders, IAW terms of contract. $0
Other Administrative Action P00011 · Covid-19 vaccine contract. Modification for reporting purposes. $0
Supplemental Agreement for work within scope P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Additional Work (new agreement, FAR part 6 applies) P00007 $2,047,500,000
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Exercise an Option P00003 $1,400,000,001
Other Administrative Action P00002 $0
Other Administrative Action P00001 · Covid-19 vaccine $0
Original award $3,500,000,001
Show all 31

About this award

Written by GovTribe AI ·

This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the Centers for Disease Control and Prevention. This contract supports the U.S. government's efforts to distribute COVID-19 vaccines globally as part of international public health initiatives.

Quick answers

Who was awarded contract W58P0521C0002?

W58P0521C0002 was awarded to Pfizer Inc. by Office of the Assistant Administrator (Bureau for Management) on July 30, 2021.

How much is contract W58P0521C0002 worth?

The government has obligated $4,150,835,100 on W58P0521C0002. Its potential value, with all options, is $6,859,517,906.

Which agency awarded contract W58P0521C0002?

Office of the Assistant Administrator (Bureau for Management) awarded W58P0521C0002, with funding from Bureau for Global Health (Washington Office).

Was contract W58P0521C0002 competed?

The extent of competition for W58P0521C0002 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login